Insider trade

Director sold ~$2.45M of KRYS shares in the open market

Traded Aug 14, 2026 · Filed Aug 14, 2026

Why it stands out

A board member of Krystal Biotech sold $2.45M of Krystal Biotech shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Director$1M+

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$2,448,280

Shares × reported transaction price

Timing vs results

11 days after results of Aug 3, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	+1.8%	−1.2%	+3.0%
30 days	+0.3%	−2.4%	+2.7%

Past results only. Not a forecast.

The transaction was executed in multiple trades ranging from $329.01 to $329.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.

Scheduled in advance5w ago

Automatic sale5w ago

Automatic sale5w ago